{
  "CitationSubset": [],
  "KeywordList": [
    [
      "COVID-19",
      "CRISPR",
      "Cas13",
      "PAC-MAN",
      "RNA virus",
      "SARS-CoV-2",
      "antiviral",
      "infectious disease"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33778788",
  "DateCompleted": {
    "Year": "2022",
    "Month": "02",
    "Day": "16"
  },
  "DateRevised": {
    "Year": "2024",
    "Month": "01",
    "Day": "04"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "23"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "100245",
      "10.1016/j.xcrm.2021.100245"
    ],
    "Journal": {
      "ISSN": "2666-3791",
      "JournalIssue": {
        "Volume": "2",
        "Issue": "4",
        "PubDate": {
          "Year": "2021",
          "Month": "Apr",
          "Day": "20"
        }
      },
      "Title": "Cell reports. Medicine",
      "ISOAbbreviation": "Cell Rep Med"
    },
    "ArticleTitle": "A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses.",
    "Pagination": {
      "StartPage": "100245",
      "MedlinePgn": "100245"
    },
    "Abstract": {
      "AbstractText": [
        "The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and variants has led to significant mortality. We recently reported that an RNA-targeting CRISPR-Cas13 system, called prophylactic antiviral CRISPR in human cells (PAC-MAN), offered an antiviral strategy against SARS-CoV-2 and influenza A virus. Here, we expand <i>in silico</i> analysis to use PAC-MAN to target a broad spectrum of human- or livestock-infectious RNA viruses with high specificity, coverage, and predicted efficiency. Our analysis reveals that a minimal set of 14 CRISPR RNAs (crRNAs) is able to target >90% of human-infectious viruses across 10 RNA virus families. We predict that a set of 5 experimentally validated crRNAs can target new SARS-CoV-2 variant sequences with zero mismatches. We also build an online resource (crispr-pacman.stanford.edu) to support community use of CRISPR-Cas13 for broad-spectrum RNA virus targeting. Our work provides a new bioinformatic resource for using CRISPR-Cas13 to target diverse RNA viruses to facilitate the development of CRISPR-based antivirals."
      ],
      "CopyrightInformation": "\u00a9 2021 The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, Stanford University, Stanford, CA 94305, USA."
          }
        ],
        "LastName": "Lin",
        "ForeName": "Xueqiu",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, Stanford University, Stanford, CA 94305, USA."
          }
        ],
        "LastName": "Liu",
        "ForeName": "Yanxia",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, Stanford University, Stanford, CA 94305, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Management Science and Engineering, Stanford University, Stanford, CA 94305, USA."
          }
        ],
        "LastName": "Chemparathy",
        "ForeName": "Augustine",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Los Altos High School, Los Altos, CA 94022, USA."
          }
        ],
        "LastName": "Pande",
        "ForeName": "Tara",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, Stanford University, Stanford, CA 94305, USA."
          }
        ],
        "LastName": "La Russa",
        "ForeName": "Marie",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioengineering, Stanford University, Stanford, CA 94305, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "ChEM-H, Stanford University, Stanford, CA 94305, USA."
          }
        ],
        "LastName": "Qi",
        "ForeName": "Lei S",
        "Initials": "LS"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cell Rep Med",
    "NlmUniqueID": "101766894",
    "ISSNLinking": "2666-3791"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Guide, CRISPR-Cas Systems"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pathology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "CRISPR-Cas Systems"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "pathology",
        "virology"
      ],
      "DescriptorName": "RNA Virus Infections"
    },
    {
      "QualifierName": [
        "genetics",
        "isolation & purification"
      ],
      "DescriptorName": "RNA Viruses"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "RNA, Guide, CRISPR-Cas Systems"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [
        "genetics",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Species Specificity"
    }
  ],
  "CoiStatement": "Provisional patents have been filed via Stanford University related to the work."
}